PAVmed Inc. (NASDAQ:PAVM – Get Free Report)’s share price passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.68 and traded as low as $0.59. PAVmed shares last traded at $0.66, with a volume of 306,343 shares traded.
Analysts Set New Price Targets
Separately, Ascendiant Capital Markets decreased their price target on PAVmed from $21.00 to $19.00 and set a “buy” rating on the stock in a research note on Monday, December 9th.
View Our Latest Analysis on PAVM
PAVmed Stock Performance
Institutional Investors Weigh In On PAVmed
An institutional investor recently raised its position in PAVmed stock. First Manhattan CO. LLC. raised its holdings in PAVmed Inc. (NASDAQ:PAVM – Free Report) by 16.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 700,000 shares of the company’s stock after buying an additional 100,000 shares during the quarter. First Manhattan CO. LLC. owned about 6.32% of PAVmed worth $439,000 at the end of the most recent quarter. 19.93% of the stock is currently owned by hedge funds and other institutional investors.
PAVmed Company Profile
PAVmed Inc focuses on acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck.
See Also
- Five stocks we like better than PAVmed
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- How to Use the MarketBeat Excel Dividend Calculator
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for PAVmed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAVmed and related companies with MarketBeat.com's FREE daily email newsletter.
